Trump signals support for legislation easing U.S. pot ban

LOS ANGELES -- President Donald Trump said Friday that he's inclined to support a bipartisan effort in Congress to ease the U.S. ban on marijuana, a proposal that would dramatically reshape the nation's legal landscape for pot users and businesses.

The federal ban that puts marijuana on the same level as LSD and heroin has created a conflict with more than two dozen states that have legalized pot in some form.

The legislation would ensure states have the right to determine the best approach to marijuana within their borders, but some U.S. restrictions would remain, including recreational sales to people under 21.

The proposal introduced Thursday has support from members of Congress from both parties, including Republican U.S. Sen. Cory Gardner of Colorado.

"I support Senator Gardner. I know exactly what he's doing," Trump told reporters in Washington, when asked about the legislation. "We're looking at it. But I probably will end up supporting that, yes."

In a statement released Thursday, Gardner said the proposal would ensure Washington respects the will of voters in each state, whether laws provide for legalization or prohibition.

He said the federal government "is closing its eyes and plugging its ears" to spreading legalization, but Washington should not interfere with any state's legal marijuana market.

Another co-sponsor, Democratic U.S. Sen. Elizabeth Warren of Massachusetts, said in a statement that Washington "needs to get out of the business of outlawing marijuana."

California, home to one in eight Americans, launched the nation's largest legal marijuana marketplace on Jan. 1. Still, businesses that have been licensed across the state are facing the threat of federal prosecution.

https://www.bnnbloomberg.ca/trump-signals-support-for-legislation-easing-u-s-pot-ban-1.1090240

Aphria News: "we are ready to serve the recreational adult use market and meet the needs of Canadians"

We are ready to serve the recreational adult use market and meet the needs of Canadians. 

Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

Canada NewsWire

LEAMINGTON, ON, June 8, 2018

LEAMINGTON, ON, June 8, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today provided the following statement in reaction to the passage of Bill C-45, the Cannabis Act, in the Senate of Canada:  

Vic Neufeld, CEO of Aphria, said, "Today's passage of Bill C-45 through the Senate is a historic milestone towards safe and legal recreational cannabis in Canada. We applaud the government's drive to establish a rational regulatory framework for adult-use cannabis that is designed to protect public health and safety, restrict access to youth, and eliminate the black market. It is a significant day that further cements Canada as the preeminent leader in the global cannabis sector."

"While we share the government's goal to create a highly regulated market, we want to ensure that the cannabis industry is well positioned to responsibly meet the needs of Canadians and effectively compete with the black market, which is operating and marketing unbound by ethical or regulatory considerations. To do this, we believe that is critical that licensed producers be allowed to use limited forms of adult focused branding to properly educate Canadians about the differences between illegal and legal products. We also continue to advocate to exempt medicinal cannabis from excise taxes to ensure that it is subject to the same considerations as other medications. We encourage government to consider these changes as Bill C-45 passes through the final stages of legalization."

"As Canada moves one step closer to adult-use cannabis legalization, 

Aphria is well positioned as a global leader in the exciting cannabis market. With growing production capacity, innovative products, R&D expertise as well as talented and experienced people, we are ready to serve the recreational adult use market and meet the needs of Canadians. We look forward to working with government as a long-term partner to continue to position Canada as global success story," added Mr. Neufeld.

About Aphria

Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.

For more information, visit: aphria.ca

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, expectations with respect to actual production volumes, expectations for future growing capacity and costs, the completion of any capital project or expansions, and expectations with respect to future production costs. 

Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE Aphria Inc.

APH Anon Biggest Seller Again Hammering APH Net Gain $7,425,427

1 Anonymous

1,500,432

17,637,400

11.755

2,124,992

25,062,827

11.794

-624,560

$7,425,427

House Positions for C:APH from 20180608 to 20180608

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
1 Anonymous	1,500,432	17,637,400	11.755	2,124,992	25,062,827	11.794	-624,560	7,425,427
79 CIBC	1,220,118	14,360,835	11.77	1,486,417	17,520,646	11.787	-266,299	3,159,811
53 Morgan Stanley	39,255	465,801	11.866	95,380	1,112,424	11.663	-56,125	646,623
76 Industrial Alliance	0			47,500	551,032	11.601	-47,500	551,032
43 Caldwell	0			40,000	470,023	11.751	-40,000	470,023
15 UBS	3,716	43,705	11.761	33,910	396,063	11.68	-30,194	352,358
65 Goldman	400	4,789	11.973	13,300	154,497	11.616	-12,900	149,708
36 Latimer	6,529	76,761	11.757	8,400	98,755	11.757	-1,871	21,994
3 AltaCorp	1,500	17,770	11.847	1,500	17,885	11.923	0	115
68 Leede	1,000	11,920	11.92	1,000	11,980	11.98	0	60
62 Haywood	3,600	42,336	11.76	3,600	42,948	11.93	0	612
70 Manulife	580	6,773	11.678	500	5,780	11.56	80	-993
25 Odlum	200	2,362	11.81	0			200	-2,362
48 Laurentian	500	5,870	11.74	0			500	-5,870
99 Jitney	116,200	1,367,957	11.772	115,600	1,362,258	11.784	600	-5,699
22 Fidelity	38,224	451,723	11.818	37,514	442,141	11.786	710	-9,582
56 Edward Jones	1,200	14,192	11.827	0			1,200	-14,192
88 Credential	1,806	21,503	11.906	410	4,738	11.556	1,396	-16,765
90 Barclays	4,400	51,835	11.781	40	469	11.725	4,360	-51,366
28 BBS	8,485	99,130	11.683	3,730	43,351	11.622	4,755	-55,779
57 Interactive	6,799	79,982	11.764	1,851	21,798	11.776	4,948	-58,184
89 Raymond James	5,250	61,310	11.678	0			5,250	-61,310
14 ITG	16,719	197,243	11.798	10,350	122,486	11.834	6,369	-74,757
39 Merrill Lynch	234,236	2,778,907	11.864	227,492	2,668,072	11.728	6,744	-110,835
83 Mackie	10,000	115,998	11.60	0			10,000	-115,998
58 Qtrade	17,510	206,596	11.799	7,045	83,159	11.804	10,465	-123,437
72 Credit Suisse	12,294	145,387	11.826	200	2,352	11.76	12,094	-143,035
74 GMP	13,595	161,100	11.85	500	5,900	11.80	13,095	-155,200
19 Desjardins	63,261	746,339	11.798	45,036	530,784	11.786	18,225	-215,555
33 Canaccord	266,645	3,144,938	11.794	247,300	2,917,771	11.799	19,345	-227,167
143 Pershing	46,551	550,876	11.834	17,190	202,951	11.806	29,361	-347,925
59 PI	36,350	422,842	11.633	3,112	36,549	11.745	33,238	-386,293
124 Questrade	162,878	1,916,367	11.766	119,925	1,409,188	11.751	42,953	-507,179
80 National Bank	183,861	2,165,739	11.779	113,287	1,328,659	11.728	70,574	-837,080
13 Instinet	233,219	2,751,187	11.797	157,079	1,835,870	11.688	76,140	-915,317
85 Scotia	456,208	5,382,835	11.799	316,709	3,714,545	11.729	139,499	-1,668,290
7 TD Sec	855,352	10,061,659	11.763	712,966	8,391,831	11.77	142,386	-1,669,828
2 RBC	454,297	5,338,968	11.752	243,790	2,868,339	11.766	210,507	-2,470,629
9 BMO Nesbitt	310,042	3,650,534	11.774	95,587	1,123,398	11.753	214,455	-2,527,136
TOTAL	6,333,212	74,561,469	11.773	6,333,212	74,561,469	11.773	0	0

What is missing in the APH Story?

Recreational of course...it's a rhetorical question :-)

So where is APH in the recreational market?  

RIGHT well

The Fact is...APH are a world class prescription provider ...

with amazing strategic expansion plans plus

and $400 Million in Cash and no debt.  

And the public float of shares is ¼ of ACB

APH total share float by June 28 will be  231,960,921.00 common shares

(210,125,411+PP=2,848,110+18,987,400 C$258,750,794. for 2,848,110+18,987,400 Common Shares )

Compare to ACB will have 1 Billion Shares Outstanding when CMED deal Closes

No doubt APH is a winner...but market makers know this too
and unfortunately they will decide when to rally the cannabis stocks and APH will rally .

But the fact is that  Anonymous sucked $129,577,096.00 profit from Buy

versus Sell Since April 13th HUGE Rally.

Just check out my posts on the anonymous manipulation taking place.

Price of PP $11.85 PP and Closed Today $12.06 today.

( its rumoured to be OVERSUBSCRIBED at $11.85.

The market manipulators held ALL Cannabis stocks down today

especially APH.

(APH  down from a 52 week high of  $24.75 Tuesday, January 9, 2018. )

But APH is a winning stock that should run to $30.00 with all their deals

and future acquisitions announcements. And that's why Shoppers(Loblaws) picked APH

Shoppers gave APH 1 of 3 contracts that are PENDING a license to sell online.

Where is the license , why the delay..it has to do with legalization of cannabis in my opinion.  

So this is overdue...Loblaws has been waiting for a license since 2016

based on the order fulfillment coming from APH delivered by Canada Post.

[url=http://toronto.citynews.ca/2018/01/19/shoppers-drug-mart-optimistic-on-pharmacies-selling-pot-signs-3rd-supply-deal/]See Loblaws Confidence About Getting The License[/url]

IMHO that's the next biggest event we have to look forward to,

Perhaps VIC has a secret plan to merge or acquire or partner to go after the recreational market?

And now we are in the quiet period, typically a PP requires a quiet period

And the fact that this PP has end date June 28 2018

Then any TSX LIsted company will be in a quiet period...until the deal closes.

( My Prediction:Pending:merger or acquisition or partnership)

When ? Good Question.

BUT I think this is the ONLY way that APH can make Billions is to add the Recreational Cannabis market to their strategic plans.

APH will have the potential to produce 20,000 kilograms of weed per month. (Vic interview)

Where are they going to sell ALL that thru worldwide prescriptions?

So let's hold on and get this puppy to $25.00-30.00 where it should be,

Vic bring us a deal that will rocket this stock in the future....

I hate to say this but I suspect Anonymous + Others

will hold APH down ... BUT it's the NEXT VERY BEST
cannabis stock to be in IF you can handle the ups and downs and the fast
drops in share price.

The market makers and the brokerages that play against
retail are buying selling and shorting over and over again.

And everytime the run the price down...STOP LOSSES are triggered,
and RETAIL takes a 10-20% loss period.

And that's why I don't use stop losses..it's all about Due Diligence
and then HOLD ON up and down. Be confident in APH.  

or play between the Bollinger Bands,SAR,Fibonacci,And News...
and day trade like many of us.

Regardless...we are probably in a quiet period until they close the deal
and get the cheque C$258,750,794 including the extra.